3D Bioprinting Market By Type 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

3D Bioprinting Market
3D Bioprinting Market: By Type (Electron beam melting, Laser beam melting, Photo polymerization, Droplet deposition and Others); By Application (Healthcare, Cosmetics, Food and Beverage and Others) - With Forecast (2016-2021)
Report Code : HCR 0105
Updated Date: 02 February, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. 3D Bioprinting – Market Overview
2. Executive Summary
3. 3D Bioprinting – Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. 3D Bioprinting – Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the 3D Bioprinting Market
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New Entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. 3D Bioprinting Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. 3D Bioprinting Market– By Type:
   6.1. Electron beam melting
   6.2. Laser beam melting
   6.3. Photo-polymerization
      6.3.1. Stereo Lithography
      6.3.2. Digital light processing
      6.3.3. Two-photon polymerization
   6.4. Droplet deposition
      6.4.1. Inkjet printing
      6.4.2. Fused deposition modeling
      6.4.3. Multi-phase jet solidification
   6.5. Others
7. 3D Bioprinting Market– By Application:
   7.1. Healthcare
   7.2. Cosmetics
   7.3. Food and Beverage
   7.4. Others
8. 3D Bioprinting Market- By Geography:
   8.1. Introduction
   8.2. Global Study
   8.3. Americas
      8.3.1. North America
      8.3.2. Brazil
      8.3.3. Argentina
      8.3.4. Others
   8.4. Europe
      8.4.1. U.K.
      8.4.2. France
      8.4.3. Germany
      8.4.4. Others
   8.5. APAC
      8.5.1. China
      8.5.2. Taiwan
      8.5.3. Japan
      8.5.4. India
      8.5.5. Others
   8.6. ROW
9. Market Entropy
   9.1. New Product Launches
   9.2. M&As, Collaborations, JVs and Partnerships
10. Company Profiles
   10.1. 3D Biotek
   10.2. 3D Systems
   10.3. Advanced Biomatrix
   10.4. Autodesk
   10.5. Avita Medical
   10.6. BD Biosciences
   10.7. Bespoke Innovations
   10.8. Bio3D Technologies
   10.9. CMC Microsystems
   10.10. CMC Microsystems
   10.11. Cyfuse Biomedical
   10.12. Digilab
   10.13. DTM
   10.14. EnvisionTEC
   10.15. Helisys Inc.
   10.16. InSphero AG
   10.17. TeVido BioDevices
   10.18. United Therapeutics
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
3D bioprinting is a technique by which viable cells and tissues are printed in 3D in a controlled environment and the final product can be used to a certain extent as a replacement for actual tissue. The technology is still very much in the nascent stages, however will soon be in a position to be commercialized on a large scale by the end of 2020. There are already a number of research centers that are experimenting with the technology today and a number of research departments of various universities that are investing in the research of this technology.

The applications for bioprinting are many ranging from the obvious healthcare industry to the cosmetic industry. Bioprinting will be able to provide replacement tissue for burn victims or anyone that needs a skin graft and can also provide certain slices of internal organ tissue. Looking at the cosmetic industry, this industry has always been infamous for testing on animals many of their products which include deodorants, lipstick, make-up and so on. The testing is done on animals to see what the side effects are and only then are these products made available. Through bioprinting, the testing can be done on skin that is printed and would provide the companies a better subject for testing rather than always looking at animals.

Although the market is still in the early stages, it its expected to be worth more than $10 billion by the end of 2020. The healthcare industry alone will be able to utilize this technology completely for R&D purposes as well.
3D Bioprinting Market

On the basis of type, this report segments the market as
  • Electron beam melting
  • Laser beam melting
  • Photo-polymerization
  • Stereo Lithography
  • Digital light processing
  • Two-photon polymerization
  • Droplet deposition
  • Inkjet printing
  • Fused deposition modeling
  • Multi-phase jet solidification
  • Others

In terms of applications, the 3D bioprinting market has been segmented across the following applications

  • Healthcare
  • Cosmetics
  • Food and Beverage
  • Others

At present, the market dynamics in the North American region are responsible for the region’s largest share of the 3D bioprinting market in terms of revenue. The need for advanced healthcare and the ability of the consumers to pay for it is driving the market in North America. Furthermore, a significant amount of research is currently underway to make advances in this field.

The market has been segmented based on the following geographies
  • APAC
  • Europe
  • Middle East and Africa
  • North America
  • South America

Some of the other companies operating in the market are listed below
  • 3D Biotek
  • 3D Systems
  • Advanced Biomatrix
  • Autodesk
  • Avita Medical

Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports